Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14181
-
14182
-
14183
-
14184
-
14185
Expression levels of myosin heavy chain and AMPK-PGC-1α pathway in the skeletal muscles.
Published 2016“…<p>The mRNA expression levels of <i>MYH1</i> (encoding MHC type IIx), <i>MYH2</i> (encoding MHC type IIa), and <i>MYH7</i> (encoding MHC type I) normalized to β2-microglobulin levels in the intercostal muscles of SBMA (<i>n</i> = 5) and ALS (<i>n</i> = 5) subjects (A–C). …”
-
14186
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
-
14187
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
-
14188
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
-
14189
Complete ELICIT TAC data.
Published 2023“…We tested 5,479 stool samples at time points across the study for 34 enteropathogens using quantitative PCR.…”
-
14190
ELICIT TAC data dictionary.
Published 2023“…We tested 5,479 stool samples at time points across the study for 34 enteropathogens using quantitative PCR.…”
-
14191
-
14192
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
Published 2015“…MR analyses found that each genetically determined one-standard-deviation decrease in log-transformed 25OHD level conferred a 2.0-fold increase in the odds of MS (95% CI: 1.7–2.5; <i>p</i> = 7.7 × 10<sup>−12</sup>; <i>I</i><sup>2</sup> = 63%, 95% CI: 0%–88%). …”
-
14193
Neither ASICs nor TRPV1 activities are affected by depletion of PI(3,4,5)P<sub>3</sub>.
Published 2015“…<p>(A) CF-PTEN is rapidly recruited to the plasma membrane anchor LDR by dimerization of FRB and FKBP upon addition of rapamycin, and the PD domain of CF-PTEN specifically dephosphorylates PI(3,4,5)P<sub>3</sub> to PI(4,5)P<sub>2</sub>. …”
-
14194
-
14195
-
14196
PrioV3 and ICSM35 antibodies inhibit accumulation of PrP<sup>Sc</sup> in ScN2a cells.
Published 2013“…<p>ScN2a cells were incubated for 24 hours at 37°C (5% CO<sub>2</sub>) with 1 or 25 µg PrioV3 and ICSM35. 25 µg NCS (Normal camel serum), and BRIC126-treated as well as untreated cells were also included. …”
-
14197
LARP1 regulates Netrin-1 microsomal translation.
Published 2016“…LARP1 depletion decreases the expression of Netrin-1 protein in microsomes in Huh7.5 cells. …”
-
14198
-
14199
-
14200